Kura Oncology, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK, INC. | 05/02/2025 | 8.18 M | $53.97 M | 3.07% | 9.36% |
BVF INC/IL | 05/15/2025 | 7.75 M | $51.18 M | 202.01% | 8.87% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 7.44 M | $49.10 M | 46.54% | 8.51% |
ARMISTICE CAPITAL, LLC | 05/15/2025 | 6.57 M | $43.38 M | 13.31% | 7.52% |
VANGUARD GROUP INC | 05/09/2025 | 4.95 M | $32.66 M | 2.68% | 5.66% |
RA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 4.00 M | $26.43 M | -10.03% | 4.58% |
STATE STREET CORP | 05/15/2025 | 3.28 M | $21.66 M | -1.89% | 3.75% |
ECOR1 CAPITAL, LLC | 05/15/2025 | 2.64 M | $17.43 B | -25.78% | 3.02% |
PROSIGHT MANAGEMENT, LP | 05/15/2025 | 2.08 M | $13.72 M | 56.85% | 2.38% |
MORGAN STANLEY | 05/15/2025 | 1.92 M | $12.69 M | -41.26% | 2.20% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 1.81 M | $11.94 M | -23.56% | 2.07% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.80 M | $11.90 M | 1.15% | 2.06% |
FRANKLIN RESOURCES INC | 05/13/2025 | 1.56 M | $10.33 M | 1.71% | 1.79% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2025 | 1.54 M | $10.19 M | 57.90% | 1.77% |
TCG CROSSOVER MANAGEMENT, LLC | 05/14/2025 | 1.42 M | $9.40 M | 0.00% | 1.63% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 1.36 M | $8.99 M | -4.46% | 1.56% |
QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 1.17 M | $7.74 M | 5.14% | 1.34% |
FORESITE CAPITAL MANAGEMENT IV, LLC | 05/15/2025 | 1.11 M | $7.34 M | -35.61% | 1.27% |
ALGERT GLOBAL LLC | 05/13/2025 | 958.49 K | $6.33 M | 8.46% | 1.10% |
ASSENAGON ASSET MANAGEMENT S.A. | 04/15/2025 | 919.08 K | $6.07 M | 1.54% | 1.05% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 828.78 K | $5.47 M | -3.97% | 0.95% |
SOFINNOVA INVESTMENTS, INC. | 05/15/2025 | 791.67 K | $5.23 M | 100.00% | 0.91% |
AQR CAPITAL MANAGEMENT LLC | 05/15/2025 | 760.33 K | $5.02 M | 407.81% | 0.87% |
TREXQUANT INVESTMENT LP | 05/14/2025 | 685.97 K | $4.53 M | 20.99% | 0.78% |
NORTHERN TRUST CORP | 05/13/2025 | 681.63 K | $4.50 M | 2.51% | 0.78% |
ALETHEA CAPITAL MANAGEMENT, LLC | 05/14/2025 | 659.18 K | $4.35 M | 18.04% | 0.75% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 623.14 K | $4.11 M | -1.94% | 0.71% |
SILVERARC CAPITAL MANAGEMENT, LLC | 05/14/2025 | 581.37 K | $3.84 M | 100.00% | 0.67% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 532.61 K | $3.52 M | -10.91% | 0.61% |
WALLEYE CAPITAL LLC | 05/14/2025 | 504.86 K | $3.33 M | -5.87% | 0.58% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 477.60 K | $3.15 M | 46.86% | 0.55% |
DAFNA CAPITAL MANAGEMENT LLC | 05/15/2025 | 463.37 K | $3.06 M | 3.35% | 0.53% |
1492 CAPITAL MANAGEMENT LLC | 05/06/2025 | 429.75 K | $2.84 M | 25.44% | 0.49% |
CANDRIAM S.C.A. | 05/14/2025 | 422.65 K | $2.79 M | 0.00% | 0.48% |
D. E. SHAW & CO., INC. | 05/15/2025 | 418.99 K | $2.77 M | -63.60% | 0.48% |
CITADEL ADVISORS LLC | 05/15/2025 | 394.24 K | $2.60 M | -60.05% | 0.45% |
MARSHALL WACE, LLP | 05/15/2025 | 392.05 K | $2.59 M | -58.68% | 0.45% |
JPMORGAN CHASE & CO | 05/12/2025 | 349.02 K | $2.30 M | -4.62% | 0.40% |
SPHERA FUNDS MANAGEMENT LTD. | 05/15/2025 | 343.52 K | $2.27 M | -43.69% | 0.39% |
RUSSELL INVESTMENTS GROUP, LTD. | 05/13/2025 | 338.86 K | $2.24 M | 13.46% | 0.39% |
ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 330.42 K | $2.18 M | 100.00% | 0.38% |
TWO SIGMA ADVISERS, LP | 05/15/2025 | 278.60 K | $1.84 M | 15.03% | 0.32% |
VOSS CAPITAL, LLC | 05/14/2025 | 250.00 K | $1.65 M | -9.09% | 0.29% |
EXODUSPOINT CAPITAL MANAGEMENT, LP | 05/14/2025 | 240.75 K | $1.59 M | -19.00% | 0.28% |
05/12/2025 | 236.95 K | $1.56 M | 100.00% | 0.27% | |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 200.81 K | $1.33 M | -1.05% | 0.23% |
RHENMAN & PARTNERS ASSET MANAGEMENT AB | 05/14/2025 | 195.00 K | $1.29 M | -38.00% | 0.22% |
BARCLAYS PLC | 05/15/2025 | 193.97 K | $1.28 M | -3.91% | 0.22% |
JUMP FINANCIAL, LLC | 05/14/2025 | 192.71 K | $1.27 M | -19.68% | 0.22% |
GRAHAM CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 174.56 K | $1.15 M | 242.62% | 0.20% |
Kura Oncology, Inc. institutional Ownership - FAQ's
During the previous two years, 247 institutional investors and hedge funds held shares of Kura Oncology, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 8.18 M
BVF INC/IL: 7.75 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 7.44 M
ARMISTICE CAPITAL, LLC: 6.57 M
VANGUARD GROUP INC: 4.95 M
RA CAPITAL MANAGEMENT, L.P.: 4 M
92.04% of Kura Oncology, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 90.08 M shares in the last 24 months. This purchase volume represents approximately $512.53 M in transactions.